Skip to main content

Find Clinical Trials

Home
Conditions
ISS Stage I Plasma Cell Myeloma

Clinical trial condition

ISS Stage I Plasma Cell Myeloma

Explore clinical trials studying ISS Stage I Plasma Cell Myeloma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

ISS Stage I Plasma Cell Myeloma trial results

Completed

Pembrolizumab and Radiation Therapy in Patients With Relapsed or Refractory Multiple Myeloma

NCT03267888

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
Locations: Emory University/Winship Cancer Institute Atlanta, Georgia, United States

View Trial Details